Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study

Thomas Purchase; George Trilloe; Haroon Ahmed; Ridhi Agarwal; Alison Bray; Kerenza Hood; Emma Thomas-Jones; Marcus J Drake; Chris Harding; Adrian Edwards

doi:10.1016/j.euf.2022.01.001

Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study

Eur Urol Focus. 2022 Jan;8(1):8-10. doi: 10.1016/j.euf.2022.01.001. Epub 2022 Jan 20.

Authors

Affiliations

¹ PRIME Centre Wales, Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK. Electronic address: purchaset2@cardiff.ac.uk.
² PRIME Centre Wales, Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.
³ Test Evaluation Research Group, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
⁴ Northern Medical Physics and Clinical Engineering, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK.
⁵ Centre for Trials Research, Cardiff University, Cardiff, UK.
⁶ Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
⁷ Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK; Department of Urology, Freeman Hospital, Newcastle-upon-Tyne, UK.

PMID: 35065904
DOI: 10.1016/j.euf.2022.01.001

Abstract

Polypharmacy and smoking are associated with higher symptom severity in men with lower urinary tract symptoms presenting to primary care. These are potentially modifiable risk factors that can be targeted when managing these patients.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Humans
Lower Urinary Tract Symptoms* / epidemiology
Male
Polypharmacy*
Primary Health Care
Risk Factors
Smoking / adverse effects
Smoking / epidemiology

Abstract

Publication types

MeSH terms

Grants and funding